CVC-backed FutureLife Group and Ethmar International to form a joint venture.

CVC-backed FutureLife Group, a European provider of IVF, fertility treatments and related genetic services, and Ethmar International, a progressive investment holding company, agreed to form a joint venture. Financial terms were not disclosed. “Access to effective fertility remains a significant global challenge. By bringing Institut Marquès to Abu Dhabi, EIH is underscoring its commitment to supporting the emirate’s ambition to become a regional and global healthcare hub. The strength and legacy of Institut Marquès in Europe demonstrate its scalability, clinical governance and ability to deliver consistently across multiple markets," EIH.